Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$558M |
| 2 |
Apple
AAPL
|
+$265M |
| 3 |
Microsoft
MSFT
|
+$209M |
| 4 |
Amazon
AMZN
|
+$197M |
| 5 |
Visa
V
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COHR
Coherent Inc
COHR
|
+$86.3M |
| 2 |
TSMC
TSM
|
+$77.2M |
| 3 |
iShares MBS ETF
MBB
|
+$44.5M |
| 4 |
KSU
Kansas City Southern
KSU
|
+$43.8M |
| 5 |
Vale
VALE
|
+$28.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.97% |
| 2 | Financials | 12.67% |
| 3 | Consumer Discretionary | 11.32% |
| 4 | Healthcare | 10.27% |
| 5 | Communication Services | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Starbucks
SBUX
$120B
| $890M | 0.56% |
7,960,689
+381,203
| +5% | +$43.1M |
|
|
52
Vale
VALE
$64.1B
| $837M | 0.53% |
36,702,026
-1,368,227
| -4% | -$28.6M |
|
53
Toyota
TM
$224B
| $810M | 0.51% |
4,633,967
+190,642
| +4% | +$31.3M |
|
54
Merck
MRK
$322B
| $802M | 0.5% |
10,316,812
-14,625
| -0.1% | -$1.09M |
|
55
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
$10.4B
| $781M | 0.49% |
18,918,042
+2,267,883
| +14% | +$90.8M |
|
56
Stryker
SYK
$125B
| $738M | 0.46% |
2,839,709
+133,531
| +5% | +$34.1M |
|
|
RDS.A
57
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $705M | 0.44% |
17,452,122
+670,355
| +4% | +$26.7M |
|
58
GSK
GSK
$104B
| $699M | 0.44% |
14,038,393
+420,805
| +3% | +$20.2M |
|
59
Lam Research
LRCX
$367B
| $694M | 0.44% |
10,665,570
+529,620
| +5% | +$33.4M |
|
60
Invesco QQQ Trust
QQQ
$453B
| $676M | 0.42% |
1,906,596
+161,652
| +9% | +$54.4M |
|
61
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.4B
| $654M | 0.41% |
20,882,316
+543,751
| +3% | +$17M |
|
62
Edwards Lifesciences
EW
$49.6B
| $638M | 0.4% |
6,157,341
+334,627
| +6% | +$31.5M |
|
63
Chevron
CVX
$392B
| $632M | 0.4% |
6,030,404
+202,825
| +3% | +$21.4M |
|
64
Capital One
COF
$128B
| $621M | 0.39% |
4,013,284
+983,352
| +32% | +$148M |
|
65
AB InBev
BUD
$170B
| $610M | 0.38% |
8,465,446
+361,739
| +4% | +$26.4M |
|
66
JD.com
JD
$44.6B
| $596M | 0.37% |
7,472,780
-399
| -0% | -$30K |
|
67
BHP
BHP
$215B
| $595M | 0.37% |
9,157,492
+210,120
| +2% | +$13.9M |
|
68
ING
ING
$99.8B
| $585M | 0.37% |
44,175,843
+2,469,750
| +6% | +$32.4M |
|
69
RTX Corp
RTX
$290B
| $573M | 0.36% |
6,714,084
+465,222
| +7% | +$39.2M |
|
|
ABB
70
DELISTED
ABB Ltd
ABB
| $572M | 0.36% |
16,824,907
+845,430
| +5% | +$28.2M |
|
71
Petrobras
PBR
$125B
| $564M | 0.35% |
46,139,406
+8,550,337
| +23% | +$84M |
|
72
ExxonMobil
XOM
$644B
| $534M | 0.34% |
8,460,136
+400,565
| +5% | +$23.9M |
|
73
CSX Corp
CSX
$93.4B
| $525M | 0.33% |
16,357,210
+856,336
| +6% | +$28.2M |
|
74
American Tower
AMT
$80.8B
| $520M | 0.33% |
1,923,986
+41,388
| +2% | +$10.5M |
|
75
SLB Ltd
SLB
$73.6B
| $497M | 0.31% |
15,516,026
+865,756
| +6% | +$26.6M |
|
Similar funds
Ken Fisher's Q2 2021 Portfolio in Review
As of Q2 2021, Ken Fisher held 1,100 positions worth $159B, up 12% from $142B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Fisher deployed $4.92B of net new capital in Q2 2021, opening 101 new positions and adding to 388 existing holdings. Its largest new stake was Organon & Co: 967,460 shares worth $29.3M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was TSMC, an estimated $77.2M trimmed.
- Ken Fisher's largest Q2 2021 buy was Organon & Co: 967,460 shares worth $29.3M.
- Ken Fisher added most to Vanguard Intermediate-Term Corporate Bond ETF in Q2 2021, an estimated $558M increase.
- Ken Fisher's biggest Q2 2021 reduction was TSMC, cutting an estimated $77.2M.
- Ken Fisher fully exited Coherent Inc in Q2 2021, selling an estimated $86.3M.
- Ken Fisher's ten largest holdings make up 32% of its $159B portfolio in Q2 2021.
- Ken Fisher opened 101 new positions and closed 90 in Q2 2021.
- Ken Fisher's portfolio value rose 12% quarter-over-quarter to $159B.
Based on Fisher Asset Management's 13F filing for Q2 2021, filed 27 Jul 2021.